- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.11. | CVRx earns Medicare win for Barostim procedure | 1 | MassDevice | ||
| 01.11. | CVRx, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| CVRX Aktie jetzt für 0€ handeln | |||||
| 30.10. | CVRx verzeichnet starkes Wachstum im dritten Quartal und setzt auf zukünftige Erstattungserfolge | 2 | Investing.com Deutsch | ||
| 30.10. | Earnings call: CVRx reports robust Q3 growth, eyes future reimbursement wins | 1 | Investing.com | ||
| 30.10. | Canaccord Genuity Group Increases CVRx (NASDAQ:CVRX) Price Target to $17.00 | 1 | MarketBeat | ||
| 30.10. | Canaccord erhöht Kursziel für CVRx-Aktie und behält Kaufempfehlung nach starken Q3-Ergebnissen bei | 2 | Investing.com Deutsch | ||
| 29.10. | CVRx GAAP EPS of -$0.57 misses by $0.10, revenue of $13.37M beats by $0.17M | 2 | Seeking Alpha | ||
| 29.10. | CVRx, Inc.: CVRx Reports Third Quarter 2024 Financial and Operating Results | 86 | GlobeNewswire (Europe) | MINNEAPOLIS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation... ► Artikel lesen | |
| 29.10. | CVRx, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 28.10. | Insights into CVRx's Upcoming Earnings | 2 | Benzinga.com | ||
| 24.10. | CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles | 1 | Investing.com | ||
| 23.10. | Cantor Fitzgerald stays positive on CVRx, reaffirms $14 stock PT after survey | 3 | Investing.com | ||
| 21.10. | Canaccord maintains Buy rating on CVRx stock | 1 | Investing.com | ||
| 21.10. | Canaccord behält Kaufempfehlung für CVRx-Aktie bei | 1 | Investing.com Deutsch | ||
| 18.10. | CVRx, Inc.: CVRx announces new CPT® Category I codes for Barostim | 1 | GlobeNewswire (USA) | ||
| 01.10. | CVRx secures additional $20 million loan tranche | 2 | Investing.com | ||
| 01.10. | CVRx, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 16.09. | CVRX Stock Gains on Unveiling of Barostim's Positive Study Data | 1 | Zacks | ||
| 12.09. | CVRx has more positive Barostim data | 1 | MassDevice | ||
| 12.09. | CVRx, Inc.: CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim | 1 | GlobeNewswire (USA) |
Seite:
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 79,69 | -0,13 % | Ihre wichtigsten Termine: Heute im Fokus: Walmart, Qualcomm, Medtronic, Nestle, Thyssenkrupp und Sto | © Foto: Charles Krupa/AP/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:00... ► Artikel lesen | |
| EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| NANO-X IMAGING | 5,890 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,325 | 0,00 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 2,95 US-Dollar | ||
| GOODRX | 4,310 | 0,00 % | GoodRx Holdings one of the most undervalued stocks, Leerink says | ||
| TALKSPACE | 3,160 | 0,00 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARMAT | 1,190 | -1,00 % | CARMAT's Aeson Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe | Milestone of 30 heart transplants post Aeson® support, passed Strong interest in Aeson® from the medical community: more than 100 European experts will share their experience at the first... ► Artikel lesen | |
| JOINT CORP | 11,310 | 0,00 % | JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3% | ||
| MIMEDX | 9,070 | 0,00 % | MIMEDX GROUP, INC. - 8-K, Current Report | ||
| HYPERFINE | 0,900 | 0,00 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 92,70 | 0,00 % | Looking Into PROCEPT BioRobotics' Recent Short Interest | ||
| PROGYNY | 13,980 | 0,00 % | Barclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00 | ||
| BIOMERICA | 0,320 | 0,00 % | Biomerica, Inc.: Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements | IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day... ► Artikel lesen | |
| ATRICURE | 36,030 | 0,00 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| LIFEMD | 5,400 | 0,00 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen |
CVRX INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 13,510 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CVRX INC finden Sie auf Wallstreet Online.
